Table 2 Patient characteristics and medical history
Characteristics | Breast Cancer N = 10 | Lung Cancer N = 10 | Non-Hodgkin Lymphoma N = 10 | Prostate Cancera N = 10 | Total N = 40 |
|---|---|---|---|---|---|
Gender, n (%) | |||||
 Male | 0 (0) | 6 (60) | 4 (40) | 10 (100) | 20 (50) |
 Female | 10 (100) | 4 (40) | 6 (60) | 0 (0) | 20 (50) |
Age | |||||
 Mean (SD) years | 47.0 (9.3) | 52.3 (17.1) | 52.8 (14.0) | 52.6 (5.7) | 51.1 (12.4) |
 Median (range) years | 51 (30–55) | 51 (34–90) | 52 (30–76) | 51 (47–64) | 52 (30–90) |
Ethnicity, n (%) | |||||
 Not Hispanic or Latino | 9 (90) | 10 (100) | 10 (100) | 7 (70) | 36 (95) |
 Missing | 1 (10) | 0 (0) | 0 (0) | 3 (30) | 4 (10) |
Racial background, n (%) | |||||
 Asian | 0 (0) | 2 (20) | 0 (0) | 1 (10) | 3 (8) |
 Black or African American | 4 (40) | 0 (0) | 0 (0) | 0 (0) | 4 (10) |
 White | 6 (60) | 8 (80) | 10 (100) | 5 (50) | 29 (73) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 4 (40) | 4 (10) |
Employment status, n (%)b | |||||
 Employed, full-time | 5 (50) | 5 (50) | 5 (50) | 6 (60) | 21 (53) |
 Employed, part-time | 3 (30) | 2 (20) | 3 (30) | 0 (0) | 8 (20) |
 Homemaker | 1 (10) | 0 (0) | 1 (10) | 0 (0) | 2 (5) |
 Unemployed | 0 (0) | 1 (10) | 0 (0) | 0 (0) | 1 (3) |
 Retired | 0 (0) | 0 (0) | 1 (10) | 0 (0) | 1 (3) |
 Disabled | 1 (10) | 2 (20) | 0 (0) | 0 (0) | 3 (8) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 4 (40) | 4 (10) |
Highest level of education, n (%)b | |||||
 Secondary/high school | 0 (0) | 1 (10) | 1 (10) | 0 (0) | 2 (5) |
 Some college | 2 (20) | 0 (0) | 1 (10) | 1 (10) | 4 (10) |
 College degree | 7 (70) | 4 (40) | 5 (50) | 4 (40) | 20 (50) |
 Postgraduate degree | 1 (10) | 5 (50) | 3 (30) | 1 (10) | 10 (25) |
 Bachelor of Science/Bachelor of Arts | 0 (0) | 0 (0) | 1 (10) | 0 (0) | 1 (3) |
 Missing | 0 (0) | 0 (0) | 1 (10) | 4 (40) | 5 (13) |
Insurance status, n (%) | |||||
 Insured, minimal out-of-pocket costs | 6 (60) | 9 (90) | 8 (80) | 4 (40) | 27 (68) |
 Insured, significant out-of-pocket costs | 4 (40) | 1 (10) | 2 (20) | 2 (20) | 9 (23) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 4 (40) | 4 (10) |
Time since cancer diagnosis, n (%) | |||||
 <  6 months | 3 (30) | 0 (0) | 2 (20) | 2 (20) | 7 (18) |
 6 months to 1 year | 4 (40) | 6 (60) | 1 (10) | 0 (0) | 11 (28) |
 1–2 years | 1 (10) | 2 (20) | 4 (40) | 1 (10) | 8 (20) |
 2–3 years | 2 (20) | 1 (10) | 0 (0) | 3 (30) | 6 (15) |
 3+ years | 0 (0) | 1 (10) | 3 (30) | 2 (20) | 6 (15) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |
Metastatic cancer | 2 (20) | 6 (60) | 4 (40) | 4 (40) | 16 (40) |
Currently receiving chemotherapy | 8 (80) | 6 (60) | 4 (40) | 3 (30) | 21 (53) |
Last chemotherapy treatment | |||||
 <  6 months | 10 (100) | 9 (90) | 7 (70) | 7 (70) | 33 (83) |
 6 months to 1 year | 0 (0) | 0 (0) | 3 (30) | 1 (10) | 4 (10) |
 1–2 years | 0 (0) | 1 (10) | 0 (0) | 0 (0) | 1 (3) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |
Recently received or currently receiving G-CSF prophylaxis | |||||
 Currently receiving | 7 (70) | 3 (30) | 1 (10) | 1 (10) | 13 (33) |
 Recently completed | 3 (30) | 7 (70) | 9 (90) | 7 (70) | 13 (33) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |
Type of G-CSF prophylaxisb | |||||
 Pegfilgrastim | 5 (50) | 4 (40) | 5 (50) | 5 (50) | 19 (48) |
 Filgrastim | 5 (50) | 6 (60) | 5 (50) | 2 (20) | 18 (45) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |
Last G-CSF treatment, n (%) | |||||
 <  6 months | 7 (70) | 9 (90) | 7 (70) | 7 (70) | 30 (75) |
 6 months to 1 year | 1 (10) | 1 (10) | 2 (20) | 1 (10) | 5 (13) |
 1–2 years | 0 (0) | 0 (0) | 1 (10) | 0 (0) | 1 (3) |
 Missing | 2 (20) | 0 (0) | 0 (0) | 2 (20) | 4 (10) |
Route of administration of G-CSF prophylaxisb | |||||
 Subcutaneous | 5 (50) | 1 (10) | 6 (60) | 3 (30) | 15 (38) |
 Intravenous | 2 (20) | 5 (50) | 2 (20) | 2 (20) | 11 (28) |
 OBI | 3 (30) | 4 (40) | 2 (20) | 3 (30) | 12 (30) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |
Have you ever used an OBI for G-CSF treatment? | |||||
 Yes | 4 (40) | 7 (70) | 4 (40) | 7 (70) | 22 (55) |
Comorbidities | |||||
 No other health condition | 10 (100) | 10 (100) | 9 (90) | 8 (80) | 37 (93) |
 Cardiovascular disease | 0 (0) | 0 (0) | 1 (10) | 0 (0) | 1 (3) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |
Health status within the past week | |||||
 Excellent | 2 (20) | 0 (0) | 3 (30) | 1 (10) | 6 (15) |
 Very good | 0 (0) | 1 (10) | 3 (30) | 2 (20) | 6 (15) |
 Good | 4 (40) | 5 (50) | 3 (30) | 3 (30) | 15 (38) |
 Fair | 4 (40) | 4 (40) | 1 (10) | 2 (20) | 11 (28) |
 Missing | 0 (0) | 0 (0) | 0 (0) | 2 (20) | 2 (5) |